Sijunzi decoction alleviates cancer cachexia myatrophy by suppressing M2 polarization of tumor-associated macrophages via the MCT1/lactate/H3K18 lactylation pathway.
2/5 보강
TL;DR
This study demonstrated that SJZD alleviated CCMA by inhibiting the MCT1/lactate/H3K18Lac pathway to reduce the M2 polarization of TAMs, thereby improving CCMA.
OpenAlex 토픽 ·
Antioxidants, Aging, Portulaca oleracea
Nutrition and Health in Aging
Immune cells in cancer
This study demonstrated that SJZD alleviated CCMA by inhibiting the MCT1/lactate/H3K18Lac pathway to reduce the M2 polarization of TAMs, thereby improving CCMA.
APA
Dengyun Nie, Yakun Zhang, et al. (2026). Sijunzi decoction alleviates cancer cachexia myatrophy by suppressing M2 polarization of tumor-associated macrophages via the MCT1/lactate/H3K18 lactylation pathway.. Journal of ethnopharmacology, 364, 121500. https://doi.org/10.1016/j.jep.2026.121500
MLA
Dengyun Nie, et al.. "Sijunzi decoction alleviates cancer cachexia myatrophy by suppressing M2 polarization of tumor-associated macrophages via the MCT1/lactate/H3K18 lactylation pathway.." Journal of ethnopharmacology, vol. 364, 2026, pp. 121500.
PMID
41796614 ↗
Abstract 한글 요약
[ETHNOPHARMACOLOGICAL RELEVANCE] Chinese expert consensus shows that Sijunzi decoction (SJZD) can improve cancer cachexia myatrophy (CCMA) in clinical, but its mechanism remains unclear.
[AIM OF THE STUDY] To explore the effects of SJZD on tumor-associated macrophages (TAMs) polarization via the monocarboxylate transporter 1 (MCT1)/lactate/histone H3K18 lactylation (H3K18Lac) pathway, thereby improving CCMA.
[MATERIALS AND METHODS] KPC pancreatic and MC38 colon cancer cachexia mice models were constructed to evaluate the therapeutic effects of SJZD on CCMA, including body weight, muscle weight, muscle fiber condition and myatrophy markers (Atrogin-1, Myostatin, MuRF1). The regulatory effects of SJZD on systemic inflammation were evaluated, including TNF-α and IL-6 levels in tumors, serums, and muscles. TAMs polarization and the MCT1/lactate/H3K18Lac pathway were analyzed in vivo and in vitro using flow cytometry and western blot. Genetic manipulation of MCT1 in TAMs was employed for mechanistic validation in vitro. The main components of SJZD and SJZD containing serum were identified by liquid chromatography-mass spectrometry analysis.
[RESULTS] SJZD, particularly at a medium dose, significantly alleviated the loss of body weight and muscle weight, downregulated myatrophy markers, reduced systemic levels of TNF-α and IL-6 in vivo. SJZD decreased lactate accumulation and downregulated MCT1 and H3K18Lac expression in TAMs, ultimately inhibited M2 polarization of TAMs. MCT1 knockdown also decreased the levels of lactate, H3K18Lac and M2 polarization in TAMs. Recovery of MCT1 expression after SJZD containing serum intervention could counteract the regulatory effects of SJZD on lactate-H3K18Lac-M2 polarization axis in TAMs.
[CONCLUSION] This study demonstrated that SJZD alleviated CCMA by inhibiting the MCT1/lactate/H3K18Lac pathway to reduce the M2 polarization of TAMs. The elucidation of the pharmacological mechanism of SJZD provided a scientific rationale for its application in CCMA treatment.
[AIM OF THE STUDY] To explore the effects of SJZD on tumor-associated macrophages (TAMs) polarization via the monocarboxylate transporter 1 (MCT1)/lactate/histone H3K18 lactylation (H3K18Lac) pathway, thereby improving CCMA.
[MATERIALS AND METHODS] KPC pancreatic and MC38 colon cancer cachexia mice models were constructed to evaluate the therapeutic effects of SJZD on CCMA, including body weight, muscle weight, muscle fiber condition and myatrophy markers (Atrogin-1, Myostatin, MuRF1). The regulatory effects of SJZD on systemic inflammation were evaluated, including TNF-α and IL-6 levels in tumors, serums, and muscles. TAMs polarization and the MCT1/lactate/H3K18Lac pathway were analyzed in vivo and in vitro using flow cytometry and western blot. Genetic manipulation of MCT1 in TAMs was employed for mechanistic validation in vitro. The main components of SJZD and SJZD containing serum were identified by liquid chromatography-mass spectrometry analysis.
[RESULTS] SJZD, particularly at a medium dose, significantly alleviated the loss of body weight and muscle weight, downregulated myatrophy markers, reduced systemic levels of TNF-α and IL-6 in vivo. SJZD decreased lactate accumulation and downregulated MCT1 and H3K18Lac expression in TAMs, ultimately inhibited M2 polarization of TAMs. MCT1 knockdown also decreased the levels of lactate, H3K18Lac and M2 polarization in TAMs. Recovery of MCT1 expression after SJZD containing serum intervention could counteract the regulatory effects of SJZD on lactate-H3K18Lac-M2 polarization axis in TAMs.
[CONCLUSION] This study demonstrated that SJZD alleviated CCMA by inhibiting the MCT1/lactate/H3K18Lac pathway to reduce the M2 polarization of TAMs. The elucidation of the pharmacological mechanism of SJZD provided a scientific rationale for its application in CCMA treatment.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Animals
- Monocarboxylic Acid Transporters
- Drugs
- Chinese Herbal
- Mice
- Cachexia
- Symporters
- Male
- Lactic Acid
- Tumor-Associated Macrophages
- Histones
- Muscular Atrophy
- Cell Line
- Tumor
- Inbred C57BL
- Signal Transduction
- Cancer cachexia myatrophy
- Lactate
- Lactylation
- Sijunzi decoction
- Tumor-associated macrophages
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- SpNeigh: spatial neighborhood and differential expression analysis for high-resolution spatial transcriptomics.
- Key Considerations for Targeting in Pancreatic Cancer: Potential Impact on the Treatment Paradigm.
- The tumor microenvironment as a key regulator of radiotherapy response.
- Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine.
- Advances in green-synthesized magnetic nanoparticles for targeted cancer therapy: mechanisms, applications, and future perspectives.
- SMURF2 in Anticancer Therapy: Dual Role in Carcinogenesis and Theranostics.